Clinical Trial Update: Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes the ongoing Phase 1/2 study of NBM-BMX in metastatic uveal melanoma, including safety, efficacy, and pharmacokinetics asses…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• NBM-BMX

Snippet

Sponsor: Novelwise Pharmaceutical Corporation | Conditions: Metastatic Uveal Melanoma, Uveal Melanoma, Metastatic | Phase 1, Phase 2 | Status: RECRUITING